dementia glp 1 GLP-1 and the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential Advances in Clinical and Experimental – Two new studies in JAMA

If GLP-1s become the first meaningful pharmacologic advancement in addiction treatment in a generation, the ripple effects across care models will be significant

[N-acetylcystein in the therapy of chronic bronchitis]

The molecular target that AOD-9604 actually binds is still unidentified, which the FDA explicitly noted in its December 2024 evaluation

However, while promising , its long-term effects on OSA outcomes beyond weight loss require further study

44 Excessive ROS can inhibit IRS1 activation by activating inflammation-related protein kinase C, inhibitor kappa B kinase (IKK), c-Jun N-terminal kinase (JNK), and p38 MAPK, thereby aggravating IR, 45 creating a vicious cycle

L-Carnitine is a naturally occurring amino acid derivative thats synthesized in the liver and kidneys from lysine and amino acid methionine